Cargando…
The missing link? LGMN connects hypoxia and immunosuppression in glioblastoma
In this issue, Pang and colleagues(1) identify the protease legumain as a potential immunotherapy target in glioblastoma that drives tumor-associated macrophages in response to hypoxia.
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694751/ https://www.ncbi.nlm.nih.gov/pubmed/37992680 http://dx.doi.org/10.1016/j.xcrm.2023.101293 |